Inspra and hypoaesthesia 
Inspra and hypoaesthesia Patient Reports February 11, 2012
Inspra Side Effects Report #5903740-8
Inspra side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2008. Male patient, 41 years of age, weighting 241.5 lb, was diagnosed with primary hyperaldosteronism and was treated with Inspra. After drug was administered, patient experienced the following side effects: chest pain
, fatigue, headache , herpes zoster, hypertension, hypoaesthesia, insomnia, joint swelling. Inspra dosage: unknown. During the same period patient was treated with CLONIDINE, GARLIC, FLAXSEED OIL, VITAMINS. Patient recovered.Inspra Side Effects Report #5012696-4
Inspra side effect was reported by a Physician from UNITED KINGDOM on May 16, 2006. Male patient, 66 years of age, weighting 134.5 lb, was diagnosed with ill-defined disorder and was treated with Inspra. After drug was administered, patient experienced the following side effects: cardiac disorder, hypoaesthesia, paraesthesia, unevaluable event. Inspra dosage: 12.5 MG (12. 5 MG, DAILY: EVERY DAY), ORAL. During the same period patient was treated with BUMETANIDE, BENDROFLUMETHIAZIDE, ENALAPRIL, NICORANDIL, CLOPIDOGREL, CARVEDILOL, SERETIDE, SALBUTAMOL. Patient died on 05/01/2006.
Inspra Side Effects Report #5960552-7
Inspra side effect was reported by a Physician from UNITED STATES on Nov 11, 2008. Male patient, weighting 244.1 lb, was diagnosed with hyperaldosteronism and was treated with Inspra. After drug was administered, patient experienced the following side effects: abdominal pain
, chest pain , fatigue, headache , herpes zoster, hypertension, hypoaesthesia, insomnia, joint swelling. Inspra dosage: unknown. During the same period patient was treated with CLONIDINE, GARLIC, FLAXSEED OIL, VITAMINS. Patient recovered.Inspra Side Effects Report #5074146-1
Inspra side effect was reported by a Physician from UNITED KINGDOM on July 24, 2006. Male patient, 66 years of age, weighting 134.5 lb, was diagnosed with cardiac failure and was treated with Inspra. After drug was administered, patient experienced the following side effects: cardiac arrest
, cardiac disorder, fall , hypertension, hypoaesthesia, hypoxic encephalopathy, paraesthesia, ventricular fibrillation. Inspra dosage: 12.5 MG (12.5 MG, DAILY: EVERY DAY), ORAL. During the same period patient was treated with BUMETANIDE, BENDROFLUMETHIAZIDE, ENALAPRIL MALEATE, NICORANDIL, CLOPIDOGREL, CARVEDILOL, SERETIDE, SALBUTAMOL. Patient died on 05/11/2006.